Allogeneic transplant in first remission for post-induction molecular MRD; circulating HSPCs actively participate in human hematopoiesis; let-7 miRNAs repress HIC2 to regulate BCL11A transcription and hemoglobin switching
May 09, 2024•22 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
In this week's episode we’ll discuss the utility of MRD in identifying patients with NPM1 AML who benefit from allogeneic transplant in first remission, learn more about the contribution of circulating hematopoietic stem/progenitor cell subsets to human hematopoietic hemostasis, and discuss the role of Let-7 miRNAs in regulation of BCL11A transcription and hemoglobin switching.
Featured Articles:
- Postinduction molecular MRD identifies patients with NPM1 AML who benefit from allogeneic transplant in first remission
- let-7 miRNAs repress HIC2 to regulate BCL11A transcription and hemoglobin switching
- Circulating Hematopoietic Stem/Progenitor Cell subsets contribute to human hematopoietic homeostasis
For the best experience, listen in Metacast app for iOS or Android